Skip to main content
The Egyptian Journal of Internal Medicine
Download PDF

Study of the effect of metformin therapy on thyroid function in type 2 diabetic patients

The Egyptian Journal of Internal Medicine volume 31, pages 972–978 (2019)Cite this article

Abstract

Background

Metformin, the most widely used antidiabetic drug, is considered as the cornerstone of type 2 diabetes treatments. Surprisingly, a few years ago, it has been reported that serum thyroid-stimulating hormone (TSH) level in hypothyroid patients decreased in response to metformin therapy and increased again when metformin was discontinued. This study was performed at the Diabetic Outpatient Clinic and Internal Medicine Department at Assiut University Hospital during the period between January and June 2017.

Aim

The study aimed to assess the effect of metformin treatment on TSH in type 2 diabetic patients with or without thyroid dysfunction.

Results

A total of 100 patients, with type 2 diabetes mellitus, were enrolled in the study. The patients were divided into two groups: group I included 50 patients on metformin therapy and group II included 50 patients without metformin therapy. Their age was equal to or more than 40 years; their duration of diabetic treatment was equal to or more than 5 years.

Conclusion

In conclusion, there were significant relationships between TSH levels and metformin therapy, obesity, macroangiopathy, and hyperlipidemia, as the treatment with metformin caused suppression of TSH to subnormal levels without any change in free T4 or frees T3 in diabetic patients.

References

  1. Shoback DG, Gardner D, eds. Greenspan’s basic& clinical endocrinology. ISBN 9780071622431. (9th ed.). California, San Francisco: McGraw-Hill Medical; 2011.

  2. The American Society of Health-System Pharmacists. Metformin hydrochloride. December 24, 2016. https://it.m.wikipedia.org/wiki/Metformin. [Accessed January 2, 2017].

  3. Ganesan A, Proudfoot J. Analogue-based drug discovery. Fischer J, Ganellin CR, editors. Wiley-VCH; 2010 Jul. ISBN:978-3-527-31257-3.

  4. World Health Organization. The selection and use of essential medicines: report of the WHO Expert Committee, 2015 (including the 19th WHO Model List of Essential Medicines and the 5th WHO Model List of Essential Medicines for Children). Geneva, Switzerland: World Health Organization; 2015.

    Google Scholar 

  5. Diabetes Prevention Program Research Group. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 2002; 346:393–403.

    Article  Google Scholar 

  6. Kadiyala R, Peter R, Okosieme OE. Thyroid dysfunction in patients with diabetes: clinical implications and screening strategies. Int J Clin Pract 2010; 64:1130–1139.

    Article  CAS  Google Scholar 

  7. Boron WF, Boulpaep EL. Medical physiology, 2e updated edition E-book: with student consult online access. British Medical Association: Elsevier Health Sciences; 2012.

  8. Kokkoris P, Pi-Sunyer FX. Obesity and endocrine disease. Endocrinol Metab Clin North Am 2003; 32:895–914.

    Article  CAS  Google Scholar 

  9. Azoulay L, Filion KB, Platt RW, Dahl M, Dormuth CR, Clemens KK, et al. Association between incretin-based drugs and the risk of acute pancreatitis. JAMA Inter Med 2016; 176:1464–1473.

    Article  Google Scholar 

  10. Capelli M, Leporati P, La Manna A, Pirali B, Magri F, Chiovato L, et al. Raised serum TSH levels in patients with morbid obesity: is it enough to diagnose subclinical hypothyroidism?. Eur J Endocrinol 2009; 160:403–408.

    Article  Google Scholar 

  11. Vigersky RA, Filmore-Nassar A, Glass AR. Thyrotropin suppression by metformin. J Clin Endocrinol Metab 2006; 91:225–227.

    Article  CAS  Google Scholar 

  12. Díez JJ, Iglesias P. Relationship between serum thyrotropin concentrations and metformin therapy in euthyroid patients with type 2 diabetes. Clin Endocrinol (Oxf) 2013; 78:505–511.

    Article  Google Scholar 

  13. Nurcheshmeh M, Green D, Byrne C, Habib A. Prediction of sheet metal forming limits in multistage forming processes. IOP Conference Series: Materials Science and Engineering 2018 Sep (Vol. 418, No. 1, p. 012045). IOP Publishing.

  14. Ittermann T, Markus MR, Schipf S, Derwahl KM, Meisinger C, Volzke H, et al. Metformin inhibits goitrogenous effects of type 2 diabetes. Eur J Endocrinol 2013; 169:9–15.

    Article  CAS  Google Scholar 

  15. Blanc E, Ponce C, Brodschi D, Nepote A, Barreto A, Schnitman M, et al. Association between worse metabolic control and increased thyroid volume and nodular disease in elderly adults with metabolic syndrome. Metab Synd Relat Disord 2015; 13:221–226.

    Article  CAS  Google Scholar 

  16. Chakraborty PP, Ray S, Biswas D, Baidya A, Bhattacharjee R, Mukhopadhyay P, et al. A comparative study between total contact cast and pressure-relieving ankle foot orthosis in diabetic neuropathic foot ulcers. J Diabetes Sci Technol 2014; 9:302–308.

    Article  Google Scholar 

  17. Cappelli C, Pirola I, Mittempergher F, De Martino E, Casella C, Agosti B, et al. Morbid obesity in women is associated to a lower prevalence of thyroid nodules. Obes Surg 2012; 22:460–464.

    Article  Google Scholar 

  18. Ravishankar D, Rajora AK, Greco F, Osborn HM. Flavonoids as prospective compounds for anti-cancer therapy. Int J Biochem Cell Biol 2013; 45:2821–2831.

    Article  CAS  Google Scholar 

  19. Khurana R, Malik IS. Metformin: safety in cardiac patients. Heart 2010; 96:99–102.

    CAS  PubMed  Google Scholar 

  20. Vikhe VB, Kanitkar SA, Tamakuwala KK, Gaikwad AN, Kalyan M, Agarwal RR, et al. Thyroid dysfunction in patients with type 2 diabetes mellitus at tertiary care centre. Natl J Med Res 2013; 3:377–380.

    Google Scholar 

  21. Alevizaki M. Metformin and the thyroid: some questions still remain. Clin Endocrinol 2013; 78:503–504.

    Article  CAS  Google Scholar 

  22. Fournier JP, Yin H, Yu OH, Azoulay L. Metformin and low levels of thyroid-stimulating hormone in patients with type 2 diabetes mellitus. Can Med Assoc J 2014; 186:1138–1145.

    Article  Google Scholar 

  23. Cappelli C, Rotondi M, Pirola I, Agosti B, Gandossi E, Valentini U, et al. TSH-lowering effect of metformin in type 2 diabetic patients: differences between euthyroid, untreated hypothyroid, and euthyroid on L-T4 therapy patients. Diabetes Care 2009; 32:1589–1590.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Internal Medicine, Faculty of Medicine, Assiut University, Assiut, Egypt

    Fatema A. Abdelmoez (Proffesor of Internal Medicine), Ghada A. Mohamed & Dina M. S. Eldine

Authors
  1. Fatema A. Abdelmoez
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Ghada A. Mohamed
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Dina M. S. Eldine
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Fatema A. Abdelmoez.

Additional information

This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.

Rights and permissions

This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Abdelmoez, F.A., Mohamed, G.A. & Eldine, D.M.S. Study of the effect of metformin therapy on thyroid function in type 2 diabetic patients. Egypt J Intern Med 31, 972–978 (2019). https://doi.org/10.4103/ejim.ejim_148_19

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.4103/ejim.ejim_148_19

Keywords